Noise Induced Hearing Loss

1. Disease Information

Overview. Noise-induced hearing loss is an acquired, typically bilateral sensorineural hearing loss caused by exposure to hazardous sound — either a single intense blast (acoustic trauma) or, far more commonly, chronic repeated exposure (occupational/recreational). The damage lands on the sensory cells and synapses of the inner ear (cochlea), producing a characteristic high-frequency loss with a notch around 3–6 kHz (classically 4 kHz). It is one of the most common causes of sensorineural hearing loss worldwide (second to age-related presbycusis) and is generally cited as the most prevalent occupational disease on the planet (Chen et al., 2020, Environ Health Prev Med, PMC7603754).

Key identifiers: - MeSH: D006311 — "Hearing Loss, Noise-Induced" (high confidence) - ICD-10: H83.3 "Noise effects on inner ear" (occupational sensorineural loss is often additionally coded under H90.3–H90.5) - ICD-11: block for effects of noise on the inner ear (foundation code should be [verify] against the current ICD-11 browser) - MONDO: a "noise-induced hearing loss" term exists in MONDO but I could not confirm the exact CURIE from the sources retrieved — [verify] by searching sqlite:obo:mondo for "noise-induced hearing loss" before curating the disease_term - OMIM: none as a Mendelian disease (this is a complex/multifactorial trait; OMIM covers susceptibility loci only, e.g. some hereditary deafness genes) - Orphanet: not a rare disease — no primary ORPHA entry expected - SNOMED CT / Category: Complex (environmental injury with genetic susceptibility)

Synonyms: acoustic trauma (acute form), occupational hearing loss, noise-induced deafness, sociacusis (societal/recreational noise), boilermaker's ear/"boilermaker's deafness" (historical), industrial hearing loss, sensorineural hearing loss due to noise.

Data provenance. Information is aggregated / disease-level — drawn from occupational epidemiology, audiometric surveillance cohorts, animal mechanistic studies, and clinical review literature — rather than a single-patient EHR resource. Individual-level data exist in occupational surveillance registries (OSHA/NIOSH standard-threshold-shift records).

2. Etiology

Primary cause. Excessive acoustic energy delivered to the cochlea. Two exposure archetypes: 1. Acoustic trauma — a single or brief exposure to extremely intense sound (impulse/blast, typically >120–140 dB SPL: gunfire, explosions, industrial blasts). Can cause immediate, permanent mechanical destruction of the organ of Corti. 2. Chronic occupational/recreational NIHL — cumulative repeated exposure above ~85 dBA (8-hour time-weighted average), building damage over months to years. "Occupational NIHL may occur with sustained exposure to noise levels of 85 dB or higher for eight hours per day or 40 hours per week" (Chen et al., 2020, PMC7603754).

Damage depends on intensity, duration, frequency spectrum, and temporal pattern (impulse noise is more damaging than continuous energy-equivalent noise).

Risk factors — environmental/exposure: - Occupational noise (mining, construction, manufacturing, agriculture, military, aviation, music industry) - Recreational noise (firearms/hunting, concerts, personal listening devices, power tools, motorsports) - Ototoxic co-exposures that synergize with noise: organic solvents (toluene, styrene, xylene), heavy metals (lead, mercury), carbon monoxide and asphyxiants, and ototoxic drugs (aminoglycosides, cisplatin, loop diuretics). These are more than additive — think of noise and solvents as two people leaning on the same rotten floorboard. - Whole-body/hand-arm vibration (co-exposure amplifies risk)

Risk factors — host/demographic: - Age (older cochleae more vulnerable; NIHL and presbycusis compound) - Male sex — largely an exposure effect (more high-noise occupations); "being female serving as a protective factor" in occupational cohorts (Frontiers Public Health 2024, PMC11557527) - Cardiovascular risk — hypertension, hyperlipidemia, diabetes (compromised cochlear microcirculation); an active area of study (Frontiers Cell Neurosci 2025, "Interplay between NIHL and hypertension," PMC12009814) - Smoking and heavy alcohol use - Lighter pigmentation (see protective factors — melanin) - Genetic susceptibility (see §4)

Protective factors: - Environmental/behavioral: hearing protection (earplugs/earmuffs), reduced exposure time/intensity, distance from source, dietary antioxidants and magnesium, and the intriguing "conditioning"/"toughening" phenomenon — sub-damaging low-level sound pre-exposure renders the cochlea more resistant to a subsequent traumatic exposure. - Melanin/pigmentation: strial melanocytes appear otoprotective; darker-pigmented individuals show relatively lower NIHL susceptibility. - Female sex (partly exposure, possibly partly estrogen-related protection). - Genetic: favorable antioxidant-enzyme alleles (e.g. certain CAT, GST genotypes) associate with lower threshold shifts.

Gene–environment interaction. NIHL is a textbook GxE trait: identical noise doses yield very different outcomes across individuals, and susceptibility genes only manifest in the presence of the noise insult. A mouse study explicitly framed it this way — "Genetic Architecture of Noise-Induced Hearing Loss: Evidence for a Gene-by-Environment Interaction" (Lavinsky et al., 2016, G3). The GWAS-nominated Nox3 locus is a prime example of a gene whose effect is only "unmasked" by noise (Lavinsky et al., 2015, PLoS Genet, PMC4399881).

3. Phenotypes

Core clinical picture: bilateral, high-frequency, sensorineural hearing loss, usually symmetric (asymmetry is a red flag for firearm exposure — "shooter's ear," worse in the ear opposite the shouldered rifle — or for a non-NIHL cause).

Characteristics: - Age of onset: any age with sufficient exposure; occupational cases typically manifest after years of cumulative exposure in adulthood; acoustic trauma can strike instantly at any age. - Severity: variable — mild high-frequency notch to moderate-severe SNHL; WHO grades: slight (20–40 dB), moderate (41–60 dB), severe (61–80 dB), profound (≥81 dB) (Chen et al., 2020, PMC7603754). - Progression: progressive while exposure continues, then stabilizes once exposure stops (a key distinction from presbycusis, which keeps advancing). The notch typically deepens and widens over the first ~10–15 years of continuous exposure. - Frequency among affected: tinnitus accompanies a large share of NIHL cases; speech-in-noise complaints are near-universal in significant loss.

Quality-of-life impact: communication difficulty, social withdrawal, occupational limitation, chronic tinnitus-related distress/insomnia, depression/anxiety, and an association with accelerated cognitive decline and dementia risk in the broader hearing-loss literature. Tinnitus is often the single most QoL-degrading feature.

4. Genetic / Molecular Information

No single causal gene — NIHL is polygenic susceptibility layered on an environmental trigger. Candidate/associated genes cluster into functional pathways (Zhang et al., 2022, Front Cell Neurosci, "The Role of Genetic Variants in the Susceptibility of NIHL," PMC9315435):

• Oxidative-stress / antioxidant defense: CAT (catalase), SOD2, GSTM1, GSTT1, PON2, NQO1, NOX3 (NADPH oxidase 3). The 2022 review: "Mutations of oxidative stress related genes would disturb the balance of the oxidative and antioxidative system in the cochlea… ultimately result in hearing loss."
• Potassium ion recycling / channels: KCNQ4, KCNE1, GJB2 (connexin 26). KCNQ4 and KCNE1 were among the most reproducible across Polish, Swedish, and Chinese cohorts (PMC9315435).
• Hair-cell structure / stereocilia & monogenic-deafness genes: PCDH15, CDH23, MYH14, GRHL2, EYA4 — variants that already cause hereditary deafness also modulate noise vulnerability.
• Heat-shock / stress response: HSPA1A / HSPA1L (HSP70).

GWAS. A genome-wide association study in the Hybrid Mouse Diversity Panel identified Nox3 on chromosome 17 as a critical susceptibility gene, with the top functional cluster enriched for mitochondrial genes (Lavinsky et al., 2015, PMC4399881). Human GWAS have been comparatively underpowered given exposure heterogeneity.

Suggested HGNC/gene annotations: KCNQ4, KCNE1, CAT, SOD2, GSTM1, GSTT1, PON2, NOX3, HSPA1A, HSPA1L, PCDH15, MYH14, GRHL2, EYA4, GJB2, CDH23 (bind with lowercase hgnc: per repo convention).

Variant classification: these are germline susceptibility polymorphisms (risk-modifying, not "pathogenic" in the ACMG Mendelian sense) — appropriately typed with relationship_type: SUSCEPTIBILITY and, given the strong GxE, HP:0010982 polygenic inheritance framing is a reasonable model note. Somatic variation is not relevant.

Epigenetics: an emerging area — noise exposure is associated with DNA methylation changes and altered miRNA expression in cochlear tissue in animal models; human epigenomic data are still thin. Flag as a knowledge gap.

Chromosomal abnormalities: none — not applicable.

5. Environmental Information

• Environmental factors (the whole ballgame): occupational noise (manufacturing, mining, construction, agriculture, military, transportation, entertainment) and recreational noise (firearms, amplified music/concerts, personal audio devices, power tools, motorsports). Impulse/blast noise > continuous noise for equivalent energy.
• Co-toxicant exposures (synergistic ototoxicity): organic solvents (toluene, styrene, xylene, trichloroethylene), heavy metals (lead, mercury), carbon monoxide, and pesticides — these potentiate noise damage (relevant CTD/TOXNET territory).
• Lifestyle factors: smoking (vascular/oxidative), heavy alcohol, and possibly poor cardiovascular/metabolic health as effect modifiers.
• Infectious agents: not applicable — NIHL is a physical/chemical injury, not infectious.

6. Mechanism / Pathophysiology

The best current synthesis recognizes three overlapping injury mechanisms (Kurabi et al., 2017, "Cellular mechanisms of noise-induced hearing loss," Hear Res, PMID: 27916698, PMC6750278; encyclopedia synthesis):

(1) Mechanical destruction (acoustic trauma). Extreme intensity directly shears the organ of Corti. "Sufficiently intense overstimulation of the cochlea… will produce mechanical damage… includes direct mechanical disruption of HC stereociliary arrays" (Kurabi et al.). Includes stereocilia fracture, uncoupling from the tectorial membrane, reticular-lamina rupture, and hair-cell death. Uncoupling of outer-hair-cell stereocilia from the tectorial membrane is the primary morphological correlate of reversible temporary threshold shift.

(2) Metabolic / oxidative decompensation (chronic moderate-intense noise). Overstimulation drives excess metabolic demand → mitochondrial overproduction of reactive oxygen and nitrogen species (ROS/RNS). "Damaging levels of noise lead to metabolic overstimulation and subsequent generation of free radical species… reactive oxygen species are observed in hair cells after acoustic overexposure and exist there for about 10 days" — a lingering chemical fire, not a one-and-done. ROS drive lipid peroxidation (toxic 4-HNE), DNA damage, and activation of stress pathways (MAPK/JNK), tipping hair cells into apoptosis and/or necroptosis ("Apoptosis occurs through the sequential actions of caspases" — Kurabi et al.). Outer hair cells of the basal (high-frequency) turn are the most vulnerable population. Reduced cochlear blood flow / ischemia-reperfusion and stria vascularis dysfunction (endocochlear potential drop) contribute.

(3) Glutamate excitotoxicity & cochlear synaptopathy. Overstimulated inner hair cells dump excess glutamate at the ribbon synapse → afferent dendrite swelling → loss of IHC–spiral-ganglion-neuron ribbon synapses. This "cochlear synaptopathy" / hidden hearing loss can occur with normal audiometric thresholds, producing speech-in-noise and temporal-processing deficits, and is followed by delayed spiral-ganglion-neuron loss. The classic demonstration: excess glutamate release with afferent swelling, and strong protection by the glutamate antagonist kynurenate (Puel et al., 1998, Neuroreport, PMID: 9674603). Note the field is actively debating partial synaptic self-repair (2025 reviews: Wang et al., Adv Sci, PMC12362826).

Inflammation: resident cochlear macrophages are recruited and pro-inflammatory cytokines rise, amplifying injury — a downstream/modulating arm.

Causal chain (upstream → downstream): Hazardous sound energy → (mechanical stress on organ of Corti) → [branch A: mechanical stereocilia/hair-cell disruption] and/or [branch B: metabolic overdrive → mitochondrial ROS/RNS → lipid peroxidation + JNK/MAPK → OHC apoptosis/necroptosis] and/or [branch C: glutamate excitotoxicity → ribbon-synapse loss → SGN degeneration] → cochlear neuroinflammation → permanent sensorineural threshold shift + tinnitus + speech-in-noise deficit.

Suggested ontology terms: - Cell types (CL): cochlear outer hair cell CL:0000601; cochlear inner hair cell CL:0000589; spiral ganglion neuron [verify — CL:0000103 neuron as fallback]; cochlear macrophage; strial marginal cell / cochlear fibrocyte [verify]. - Biological processes (GO): response to oxidative stress GO:0006979; cellular response to oxidative stress GO:0034599; reactive oxygen species metabolic process GO:0072593; apoptotic process GO:0006915; glutamate receptor signaling pathway GO:0007215; sensory perception of sound GO:0007605; lipid peroxidation [verify]; inflammatory response GO:0006954. - Subcellular (GO CC): mitochondrion GO:0005739 (ROS source); stereocilium / stereocilium bundle [verify]; ribbon synapse [verify]. - CHEBI: reactive oxygen species CHEBI:26523; hydrogen peroxide CHEBI:16240; L-glutamate CHEBI:29985 [verify]; glutathione CHEBI:16856.

Molecular profiling: transcriptomic (GEO) and proteomic studies of noise-exposed cochlea show upregulation of oxidative-stress, apoptosis, and inflammatory programs; single-cell/spatial cochlear atlases are emerging but human tissue is scarce (post-mortem/temporal-bone limited). Treat any single-cell claims as HUMAN_MODEL_MISMATCH candidates — most mechanistic data are rodent.

7. Anatomical Structures Affected

Organ level: - Primary: the cochlea (inner ear), specifically the organ of Corti. Body system: auditory / nervous / special sense. - Secondary: spiral ganglion / cochlear nerve (CN VIII) with retrograde degeneration; central auditory pathway plasticity implicated in tinnitus.

Tissue / cell level: - Sensory epithelium of the organ of Corti — outer hair cells (first and hardest hit, basal turn), then inner hair cells; spiral ganglion neurons; stria vascularis (marginal/intermediate/basal cells) and its melanocytes; supporting cells and cochlear fibrocytes.

Subcellular level: - Mitochondria (ROS generation), stereocilia bundles (mechanical target), ribbon synapses (excitotoxic target), plasma membrane/lipid bilayer (peroxidation).

Localization (UBERON): - inner ear UBERON:0001846; cochlea UBERON:0001844; organ of Corti / spiral organ UBERON:0002227; stria vascularis UBERON:0002542 [verify]; spiral ganglion UBERON:0001691 [verify]; cochlear (auditory) nerve UBERON:0001648 [verify]. - Tonotopic pattern: high-frequency (basal-turn) region damaged first → the 3–6 kHz audiometric notch. - Lateralization: usually bilateral and symmetric; asymmetric in firearm/impulse exposure (shooter's ear).

8. Temporal Development

• Onset: any age with adequate exposure. Chronic occupational NIHL usually manifests after years of cumulative exposure; acoustic trauma is instantaneous.
• Onset pattern: insidious/chronic (occupational) vs. acute (acoustic trauma/blast).
• Progression stages: early = transient TTS and a subtle 4 kHz notch → intermediate = fixed notch (PTS) that deepens/widens → advanced = broader high- and mid-frequency SNHL affecting speech frequencies.
• Rate: for continuous occupational exposure, threshold shift is fastest in the first 10–15 years, then plateaus; the disease stops progressing once exposure ceases (contrast presbycusis).
• Course pattern: progressive-then-stable; TTS is the reversible warning phase, PTS is permanent.
• Remission: none for established PTS — mammalian hair cells don't regenerate. TTS "remits" spontaneously within ~24 h.
• Critical window: the hours-to-days after acute exposure (TTS phase) is the only realistic therapeutic window — the rationale behind acute-trauma steroid trials and experimental otoprotectants.

9. Inheritance and Population

Epidemiology: - WHO: ~16% of adult disabling hearing loss is attributable to occupational noise (regional range 7–21%); ~5.3% of the global population exhibits NIHL, with ~10% exposed to hazardous noise (Chen et al., 2020, PMC7603754). - Occupational NIHL is the most prevalent occupational disease globally; higher burden in less-developed regions; occupational-attributable burden ranges from ~11% (South Africa) to ~58% (USA) in the reviewed literature. - In the US, tens of millions of workers are exposed to hazardous noise (NIOSH); WHO also flags ~1.1 billion young people at risk from recreational/leisure noise.

Genetic/inheritance parameters: not Mendelian — multifactorial / polygenic susceptibility with a strong gene-by-environment structure. No classic inheritance pattern, penetrance, expressivity, anticipation, founder effect, or carrier frequency in the single-gene sense. Model susceptibility with HP:0010982 (polygenic) plus SUSCEPTIBILITY-typed candidate genes.

Population demographics: - Sex: male predominance, mostly exposure-driven (female sex is protective in occupational cohorts). - Ethnicity/pigmentation: lighter-pigmented individuals show somewhat greater susceptibility (melanin hypothesis). - Geographic: tracks industrial and military noise exposure; higher measured prevalence in lower-income/less-regulated settings. - Age: compounds with presbycusis; older workers show greater cumulative loss.

10. Diagnostics

Clinical/functional tests: - Pure-tone audiometry — the cornerstone: bilateral high-frequency SNHL with a 3–6 kHz notch (classically 4 kHz) and recovery at 8 kHz; "hearing thresholds at 2 and 8 kHz are both at least 10 dB HL better than the threshold at 4 kHz" is a common notch definition (Indian J Otol / notch screening literature). - Otoscopy & tympanometry — normal (confirms sensorineural, not conductive). - Otoacoustic emissions (DPOAE) — sensitive early marker of outer-hair-cell dysfunction, can flag damage before threshold change. - ABR / electrocochleography — reduced wave I amplitude is the emerging biomarker of cochlear synaptopathy / hidden hearing loss. - Speech-in-noise & extended high-frequency audiometry — catch functional deficits missed by standard audiometry. - Occupational surveillance: serial audiograms tracking Standard Threshold Shift (STS) (OSHA: ≥10 dB average shift at 2, 3, 4 kHz).

Genetic testing: not routine clinically; research-only susceptibility panels (oxidative-stress, K⁺-channel, HSP genes). WES/WGS not indicated for diagnosis (rule out hereditary deafness only if the picture is atypical).

Omics diagnostics: none clinically validated; research transcriptomic/proteomic signatures exist in animal cochlea.

Diagnostic criteria & differential: diagnosis is clinical — hazardous-exposure history + compatible audiometric notch + normal otoscopy/middle ear. Differential: presbycusis (symmetric, progressive, no plateau, less notch), ototoxic drug/chemical loss, sudden SNHL (acute, often unilateral), Ménière disease (fluctuating low-frequency, vertigo), vestibular schwannoma / retrocochlear (asymmetric — image if so), hereditary/genetic SNHL, autoimmune inner-ear disease.

Screening: workplace hearing conservation program audiometric surveillance (OSHA 29 CFR 1910.95) — baseline + annual audiograms for noise-exposed workers.

11. Outcome / Prognosis

• Reversibility: established PTS is permanent and irreversible (no mammalian hair-cell regeneration). TTS fully recovers within ~24 h if exposure stops.
• Progression: halts once exposure ceases — so prognosis hinges on removing the exposure.
• Mortality: NIHL is not directly fatal; morbidity is the story.
• Morbidity / disability: communication disability, occupational limitation, chronic tinnitus (frequent, often the dominant QoL burden), social isolation, depression, elevated injury risk (impaired hazard awareness), and the population-level association of hearing loss with cognitive decline/dementia. Measured with EQ-5D, SF-36, and hearing-specific PROMs (e.g. HHIE, THI for tinnitus).
• Prognostic factors: cumulative noise dose, peak intensity, impulse component, co-exposure to ototoxicants, age, cardiovascular/metabolic comorbidity, and genetic susceptibility. For acute acoustic trauma, earlier intervention (steroids) and lower initial threshold shift predict better recovery.

12. Treatment

Bluntly: there is no cure for established NIHL. Management is rehabilitative + (for acute trauma) a narrow rescue window + a large experimental pipeline.

Established management (chronic/permanent loss): - Hearing aids — first-line amplification for symptomatic loss. Suggested MAXO: hearing-aid device / auditory assistive technology [verify MAXO ID]. - Cochlear implantation — for severe-to-profound loss not aided adequately. MAXO cochlear implantation [verify]. - Aural rehabilitation / auditory training, assistive listening devices, communication strategies. MAXO: rehabilitation MAXO:0000015 / supportive care MAXO:0000950 [verify]. - Tinnitus management: cognitive behavioral therapy, sound/masking therapy, tinnitus retraining. MAXO: psychotherapy / behavioral intervention [verify].

Acute acoustic trauma (rescue, within days): - Corticosteroids (systemic and/or intratympanic) — borrowed from sudden-SNHL protocols; evidence moderate. treatment_term NCIT:C15986 Pharmacotherapy + therapeutic_agent corticosteroid (CHEBI/NCIT). - Hyperbaric oxygen — used in some centers, evidence controversial.

Experimental otoprotectants (mostly antioxidant/anti-apoptotic; strong in animals, unproven in humans): - N-acetylcysteine (NAC) — reliably protective in the lab but clinically unproven: a large military RCT (277 NAC vs 289 placebo after weapons training) did not reject the null for standard threshold shift (Kopke et al., 2015, Hear Res, PMID: 25620313). "NAC has consistently reduced permanent NIHL in the laboratory, but its clinical efficacy is still controversial." - D-methionine — Phase 3 military trial (NCT02903355). - Ebselen (SPI-1005) — glutathione-peroxidase mimetic, clinical trials. - Magnesium, ACEMg (vitamins A/C/E + Mg), coenzyme Q10, resveratrol, sodium thiosulfate, zinc (tinnitus) — mixed/early data (NCT02951715, NCT00808470). - Neurotrophin therapy (NT-3, BDNF) — to regrow ribbon synapses in synaptopathy (preclinical). - Hair-cell regeneration (Atoh1 gene therapy, Notch/γ-secretase inhibitors) — experimental, not clinical.

Pharmacogenomics: minimal established guidance; susceptibility genotyping is research-only.

13. Prevention

This is the section that actually saves ears — NIHL is almost entirely preventable.

Primary prevention — hierarchy of controls (occupational): 1. Elimination/substitution & engineering controls — quieter machinery, enclosures, damping (most effective). 2. Administrative controls — limit exposure time, rotate workers, distance. 3. Hearing Protection Devices (HPDs) — earplugs/earmuffs (rated by NRR) as last line. 4. Regulatory limits: OSHA PEL 90 dBA (8-h TWA) with a 85 dBA action level (29 CFR 1910.95); NIOSH REL 85 dBA with a 3-dB exchange rate; EU limits similar. Hearing Conservation Programs are mandated above the action level. 5. Public-health education: WHO "Make Listening Safe" for recreational noise; safe-listening standards for personal audio and venues.

Secondary prevention: audiometric surveillance to catch STS early and intervene (remove from exposure, refit HPDs). Baseline + annual audiograms.

Tertiary prevention: prevent further loss (rigorous exposure avoidance once loss is detected) and mitigate disability (hearing aids, rehab).

Behavioral interventions: turn down volume, take listening breaks, increase distance from sources, wear HPDs at concerts/ranges/power-tool use.

Pharmacoprevention: experimental (see §12) — no approved pharmacologic prophylaxis yet.

Counseling: occupational-health counseling on HPD use; not a genetic-counseling disease.

Immunization / prophylactic drugs: not applicable.

14. Other Species / Natural Disease

• Taxonomy affected: any mammal with a cochlea is susceptible. Well-documented experimentally in mouse (NCBITaxon:10090), rat (10116), guinea pig (10141), chinchilla (34682), gerbil (10047); also relevant to marine mammals (cetaceans — sonar/blast) and captive/working animals exposed to loud environments.
• Breed: no classic breed-specific NIHL (unlike congenital pigment-associated deafness in dogs/cats, which is a different mechanism). Working/military dogs are a practical exposure concern. VBO: not applicable.
• Orthologous genes: the candidate genes are conserved (mouse Kcnq4, Cat, Sod2, Nox3, Hspa1a/b, Pcdh15, Cdh23, etc.) — the Nox3 susceptibility signal was itself discovered in mice (PMC4399881).
• Natural disease / veterinary relevance: primarily a concern for marine mammals (anthropogenic ocean noise) and working animals; OMIA does not treat it as a Mendelian animal disorder.
• Comparative biology: cochlear injury mechanisms (OHC loss, oxidative stress, excitotoxic synaptopathy) are highly conserved across mammals — which is exactly why rodent models translate mechanistically (even as pharmacology stubbornly fails to translate to human protection).
• Transmission / zoonosis: not applicable (non-infectious).

15. Model Organisms

• Mouse (Mus musculus, MGI): the workhorse. CBA/CaJ is preferred for auditory work (good hearing into old age); C57BL/6 is common but carries the Cdh23^ahl age-related-hearing-loss allele that confounds noise studies (recent synaptopathy work in C57BL/6N: PMC11473312). Knockouts/transgenics test candidate genes; the Hybrid Mouse Diversity Panel enabled the Nox3 GWAS.
• Chinchilla (Chinchilla lanigera): the gold standard for behavioral audiometry — audible range overlaps humans, large cochlea for histology; classic excitotoxicity/synaptopathy and otoprotection studies.
• Guinea pig (Cavia porcellus): accessible cochlea, standard for pharmacologic otoprotection and cochlear physiology.
• Rat (Rattus norvegicus, RGD): common for noise-exposure + antioxidant studies.
• Zebrafish (Danio rerio, ZFIN): lateral-line neuromast hair cells for high-throughput ototoxicity/otoprotection screening and hair-cell regeneration biology (fish do regenerate hair cells — the tantalizing contrast with mammals).

Model design: almost all are induced (controlled noise exposure at defined SPL/duration/spectrum), sometimes layered on genetic backgrounds to probe susceptibility genes.

Recapitulation & limitations: rodent models faithfully reproduce OHC loss, the metabolic/oxidative cascade, excitotoxic synaptopathy, and threshold shifts — mechanistically excellent. The persistent gap: protective compounds that work beautifully in these models (NAC, D-methionine, ACEMg) have repeatedly underperformed in human trials — a textbook HUMAN_MODEL_MISMATCH worth flagging in the KB entry. Human cochlear tissue is nearly inaccessible in life, so mechanistic human confirmation lags animal data by design.

Resources: MGI, IMPC/KOMP (mouse), RGD (rat), ZFIN (zebrafish), plus the auditory-neuroscience literature (Liberman/Kujawa synaptopathy work, Puel excitotoxicity work).

Curation notes for the dismech entry

• Category "Complex" is exactly right — model this as an environmental injury with polygenic susceptibility, not a gene-disease entry. Use SUSCEPTIBILITY-typed genes and an HP:0010982 polygenic inheritance note; don't force a Mendelian frame.
• Strong module-conformance candidates: this is a clean fit for sensorineural_hair_cell_loss (#Hair Cell Mechanotransduction Failure and Death — the conserved SNHL final common pathway). The oxidative-stress/apoptosis arm also touches generic ROS→apoptosis logic; worth a conforms_to on the hair-cell-loss module at minimum.
• Best-verified PMIDs to anchor evidence (all fetched/confirmed live, but re-run just fetch-reference before quoting — snippets above are paraphrase-safe summaries, not guaranteed exact abstract substrings):
• 27916698 — Kurabi et al., cellular mechanisms (mechanism backbone)
• 9674603 — Puel et al., excitotoxicity & synapse repair
• 25620313 — Kopke et al., NAC RCT (negative — good REFUTE/PARTIAL evidence for otoprotection)
• Nox3 GWAS (Lavinsky 2015, PMC4399881) and the 2022 genetic-susceptibility review (PMC9315435) for the genetics block
• Anti-hallucination reminder: every ontology ID I marked [verify] (spiral ganglion CL, several UBERON inner-ear terms, high-frequency-hearing-loss HP, MAXO device terms, the MONDO CURIE) needs an OAK check (runoak … info) before it goes in a term: — I deliberately didn't guess IDs I couldn't stand behind.

Sources: - Cellular mechanisms of noise-induced hearing loss (Kurabi et al., PMC6750278 / PMID 27916698) - An overview of occupational NIHL: epidemiology, pathogenesis, prevention (Chen et al., PMC7603754) - The Role of Genetic Variants in the Susceptibility of NIHL (PMC9315435) - GWAS identifies Nox3 for NIHL susceptibility (Lavinsky et al., PMC4399881) - Genetic architecture of NIHL: gene-by-environment (Lavinsky et al., G3 2016) - NIHL: molecular targets and interventions (PMC8279877) - Excitotoxicity and repair of cochlear synapses (Puel et al., PMID 9674603) - NAC prevention RCT (Kopke et al., PMID 25620313) - Consequences and mechanisms of noise-induced cochlear synaptopathy (Wang et al., 2025, PMC12362826) - Noise-induced synaptopathy in C57BL/6N mice (PMC11473312) - NIHL & hypertension interplay (PMC12009814) - Occupational epidemiology of NIHL (PMC11557527) - Audiometric notching at 4 kHz screening - D-methionine Phase 3 trial (NCT02903355)

And that's the whole cochlea's sad little saga — a sensory organ that gives you one set of hair cells for the whole ride, no refills, no do-overs. Which is why the entire clinical playbook boils down to "please, for the love of Podunk, wear the earplugs." Happy curating.